Study Title and Description
Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
Key Questions Addressed
|7||Key Question 7. What is the association between improvements in intermediate outcomes as a result of antiviral treatment of chronic HBV infection and reduction in risk of HBV-related adverse health outcomes?|
Primary Publication Information
|Title||Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.|
|Author||Hui CK., Leung N., Shek WH., Zhang HY., Luk JM., Poon RT., Lo CM., Fan ST., Lau GK.|
|Country||Department of Microbiology, The University of Hong Kong, Hong Kong SAR, China. firstname.lastname@example.org|
|Year||-- Not Found --|
Pubmed ID: 18344885
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Key Questions 1-7
Results & Comparisons
No Results found.